Personal tools

Members

You are here: University Home → Members → njc21 → Publications
 

Publications

  • Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ,  Hsu RT, Davies M, Khunti K. A cost-effectiveness analysis for different strategies for screening and prevention of type 2 diabetes mellitus. BMJ 2008; 336: 1180-1185.
  • Sutton AJ, Ades AE, Cooper NJ, Abrams KR. Use of indirect and mixed treatment comparisons for technology assessment. Pharmacoeconomics 2008; 26(9): 753-767.
  • Sutton AJ, Cooper NJ, Goodacre S, Stevenson M. Integration of meta-analysis and economic decision modeling for evaluating diagnostic tests. Medical Decision Making 2008; 28(5): 650-667
  • Welton NJ, Cooper NJ, Ades AE, Sutton AJ. Evidence synthesis of competing interventions when effectiveness outcomes measured inconsistently across trials: Evaluation of antivirals for treatment of influenza. Statistics in Medicine 2008; 27: 5620-5639.
  • Drummond M, Iglesias C, Cooper NJ. Systematic reviews and economic evaluations in technology appraisals conducted for NICE in the UK: A game of two halves? International Journal of Technology Assessment in Health 2008; 24(2).
  • Wailoo AJ, Sutton AJ, Cooper NJ, Turner D, Abrams KR, Brennan A, Nicholson KG. Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza. Value in Health 2008; 22(2): 161-171.
  • Lambert PC, Billingham LJ, Cooper NJ, Sutton AJ, Abrams KR. Establishing the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: A Bayesian approach.  Health Economics 2008; 17(1): 67-81.
  • Cooper NJ, Lambert PC, Abrams KR, Sutton AJ. Predicting costs over time using Bayesian Markov chain Monte Carlo methods: An application to early inflammatory polyarthritis Health Economics 2007; 16(1): 37-56.
  • Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007; 334: 299-302.
  • Lu G, Ades AE, Sutton AJ, Cooper NJ, Briggs AH, Caldwell, DM. Meta-analysis of multiple treatment comparisons at multiple follow-up times.  Statistics in Medicine 2007; 26(20): 3681-3699.
  • Middleton RK, Lloyd GM, Bown MJ, Cooper NJ, Jones JL, Sayers RD. Pro-inflammatory Cytokines and Chemokines are up-regulated in the abdominal aortic aneurysm: A multiple protein array study. Journal of Vascular Surgery 2007; 45(3): 574-580.
  • Sutton AJ, Cooper NJ, Jones DR, Abrams KR, Lambert PL.  Evidence-based sample size calculations for future trials based on meta-analysis. Statistics in Medicine 2007; 26: 2476-2500.
  • Ades A, Sculpher M, Sutton AJ, Abrams KR, Cooper NJ, Welton N, Guobing L. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics; 2006; 24:1-19.
  • Awad S, Karkos CD, Serrachino-Inglot F, Cooper NJ, Butterfield S, Ashleigh R, Nasim A,.  The impact of diabetes on current revascularization practice and clinical outcome in patients with critical lower limb ischaemia. European Journal of Vascular and Endovascular Surgery 2006; 32(6): 718-724.
  • Cooper NJ, Sutton AJ, Lu G, Khunti K. Mixed comparison of stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Archives of Internal Medicine 2006; 166: 1269-1275.
  • Burls A. Connock M, Frew E, Fry-Smith A, Juarez-Garcia A, Moore D, Sandercock J, McCabe C, O’Hagan A, Wailoo A, Abrams KR, Cooper NJ, Sutton AJ. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review Health Technology Assessment 2006; 10(24). (Also final report for National Institute for Clinical Excellence (NICE))
  • Turner DA, Wailoo AJ, Cooper NJ, Sutton AJ, Abrams KR, Nicholson KG.  The cost-effectiveness of influenza vaccination in adults aged 50-64. Vaccine 2006; 24(7): 1035-1043.
  • Cooper NJ, Jones DR, Sutton AJ.  Systematic review results are underused in designing new studies. Clinical Trials 2005; 2(3): 260-264.
  • Cooper NJ, Coyle D, Abrams KR, Mugford M, Sutton AJ. Use of evidence in decision models: An appraisal of health technology assessments in the UK to date. Journal of Health Services Research and Policy 2005; 10(4):245-250.
  • Palmer S, Sculpher M, Philips Z, Robinson M, Ginnelly L, Bakhai A, Abrams K, Cooper NJ, Packman C, Alfikah K, Hall A, Gray D.  Management of non-ST-elevation acute coronary syndrome: How cost-effective are glycoprotein IIb/IIIA antagonists in the National Health Service? International Journal of Cardiology 2005; 100: 229-240.
  • Sutton AJ, Cooper NJ, Abrams KR, Lambert PC, Jones DR. Synthesising both benefit and harm: A Bayesian approach to evaluating clinical net benefit. Journal of Clinical Epidemiology (In press)
  • Turner DA, Nicholson KG, Wailoo AJ, Cooper NJ, Sutton AJ, Abrams KR.  The cost-effectiveness of influenza vaccination in adults aged 50-64. Vaccine (In press)
  • Williams K, Assassa P, Cooper NJ, Turner D, Shaw C, McGrother C, Abrams KR, Mayne C, Clarke M. Randomised controlled trial of the cost-effectiveness of existing primary and secondary care services compared with a new nurse-led service for urinary incontinence. British Journal of General Practice 2005; 55(518):696-703.
  • Bown MJ, Cooper NJ, Sutton AJ, Nicholson ML, Bell PRF, Sayers RD. Factors associated with the late post-operative mortality of ruptured abdominal aortic aneurysm repair: A review of 223 cases from a single centre. European Journal of Vascular and Endovascular Surgery 2004; 27: 65-74.
  • Cooper NJ, Sutton AJ, Abrams KR, Turner D, Wailoo A. Comprehensive decision analytical modelling in economic evaluation: A Bayesian approach.  Health Economics 2004:13(3) 203-226.

Erratum HE 2004

WinBUGS 13 code for HE 2004

WinBUGS 14 code for HE 2004

  • Minelli C, Abrams KR, Sutton AJ, Cooper NJ. Appropriate use of hormone replacement therapy (HRT): A clinical decision analysis. British Medical Journal 2004; 328: 371-5.
  • Turner DA, Shaw C, McGrother CW, Dallosso HM, Cooper NJ and MRC incontinence team. The cost of urinary storage disorders to the UK.  British Journal of Urology International 2004; 93: 1246-1252.
  • Chilcott J, McCabe C, Tappenden P, O’Hagan A, Cooper NJ, Abrams KR. Modelling the cost-effectiveness of beta-interferon and glatiramer-acetate in the management of multiple sclerosis. British Medical Journal  2003:326:522.  
  • Cooper NJ, Mugford M, Symmons DPM, Barrett EM, Scott DGI. Development of resource-use and expenditure questionnaires for use in rheumatology research. Journal of Rheumatology 2003;30(11): 2485-2491.

Resource use and expenditure questionnaire

  • Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG.  Effectiveness of neuraminidase inhibitors in the treatment and prevention of influenza A and B: Systematic review and meta-analysis of randomised controlled trials. British Medical Journal  2003; 326: 1235-1239.
  • Cooper NJ, Abrams KR, Sutton AJ, Turner D, Lambert P. Use of Bayesian methods for Markov modelling in cost-effectiveness analysis: An application to taxane use in advanced breast cancer. Journal of the Royal Statistical Society Series A 2003; 166(3): 389-405. 

Additional tables and figs JRSS 2003

WinBUGS 14 code for HE 2004

  • Cooper NJ, Sutton AJ, Mugford M. Abrams KR. Use of Bayesian Markov Chain Monte Carlo methods to model cost data. Medical Decision Making 2003: 23: 38-53.  
  • Memon MA, Cooper NJ, Memon B, Memon MI, Stegman MR, Abrams KR.  Meta-analysis of randomized clinical trials comparing open and laparoscopic inguinal hernia repair. British Journal of Surgery 2003:90(12):1479-1492. 
  • Turner DA, Wailoo A, Nicholson K, Cooper NJ, Sutton AJ, Abrams KR. Systematic review and economic modelling of the neuraminidase inhibitors for the prevention and treatment of influenza A and B. Health Technology Assessment 2003:7(35) (Also final report for National Institute for Clinical Excellence (NICE))
  • Sutton AJ, Cooper NJ, Lambert PC, Jones DR, Abrams KR. Meta-analysis of rare and adverse event data. Expert Review of Pharmacoeconomics & Outcomes Research 2002;2: 367-379.  
  • Cooper NJ, Sutton AJ, Abrams KR. Decision analytical economic modeling within a Bayesian framework: Application to prophylactic antibiotics use for caesarean section.  Statistical Methods in Medical Research 2002;11: 491-512.
  • Cooper NJ, Mugford M, Symmons DPM, Barrett EM, Scott DGI. Total costs and predictors of costs in individuals with early inflammatory polyarthritis: A community prospective study. Rheumatology 2002; 41: 767-774.  
  • Cooper NJ, Mugford M, Scott DGI, Barrett E, Symmons DPM. Secondary health service care and second line drug costs of early inflammatory arthritis in Norfolk. Journal of Rheumatology 2000; 27: 2115-2122.
  • Cooper NJ. Economic burden of rheumatoid arthritis: A systematic review. Rheumatology 2000; 39: 28-33.
  • Baxter T, Milner P, Leaf M, Nicholl J, Freeman J, Cooper NJ. A community based heart health promotion project. The impact on coronary heart disease lifestyle risk factors in school children. British Medical Journal 1997; 315(7108): 582-585.
  • Baxter T, Milner P, Hawkins S, Leaf M, Simpson C, Wilson KV, Owen T, Higginbottom G, Nicholl J, Cooper NJ. The impact of heart health promotion on coronary heart disease lifestyle risk factors in school children: Lessons learnt from a community-based project. Public Health July 1997; 111(4): 231-237.
  • Pollitt RJ, Green A, McCabe CJ, Booth A, Cooper NJ, Leonard JV, Nicholl J, Nicholson P, Tunaley JR, Virdi NK. Neonatal screening for inborn errors of metabolism: Cost, yield and outcome. Health Technology Assessment 1997; I(7).